Effect of diallyl trisulfide on the activation of T cell and macrophage-mediated cytotoxicity
At high concentration (50 micrograms/ml), diallyl trisulfide (DATS) had an inhibitory effect on T cell activation (compared with control group, P < 0.05). But at appropriate concentrations (3.125-12.5 micrograms/ml), DATS augmented the activation of T lymphocytes by Con A (compared with control g...
Saved in:
| Published in | Journal of Tongji Medical University Vol. 14; no. 3; p. 142 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
China
01.09.1994
|
| Subjects | |
| Online Access | Get more information |
| ISSN | 0257-716X |
| DOI | 10.1007/BF02886794 |
Cover
| Abstract | At high concentration (50 micrograms/ml), diallyl trisulfide (DATS) had an inhibitory effect on T cell activation (compared with control group, P < 0.05). But at appropriate concentrations (3.125-12.5 micrograms/ml), DATS augmented the activation of T lymphocytes by Con A (compared with control group, P < 0.01). The augmentation of T cell activation by DATS was related to its inhibitory effect on the production of nitric oxide (NO) by macrophages. In a wide range of concentrations (1-100 micrograms/ml), DATS can inhibit the production of NO by macrophages (P < 0.05, P < 0.01). In addition, DATS can antagonize the inhibition of tumor-derived immunosuppressive factors produced by S180 cells and Ehrlich ascitic cancer cells on the activation of T cells, and reduce the inhibitory rate significantly (P < 0.01). DATS, despite its inhibition of the production of NO by macrophages, can significantly enhance the production of hydrogen peroxide (H2O2) by macrophages. When macrophages were pretreated with DATS for 24 h, the cytotoxicity % of macrophages to three tumor cell lines was significantly higher than that in corresponding control group (P < 0.05, P < 0.01). In the presence of both DATS and LPS, the cytotoxicity of macrophages was further enhanced so that the cytotoxicity % of macrophages to tumor cells was significantly higher than either that in the presence of DATS alone or that in the presence of LPS alone (P < 0.05, P < 0.01). These results indicate that DATS can augment the activation of T cells and enhance the anti-tumor function of macrophage, suggesting that DATS may be potentially useful in tumor therapy. |
|---|---|
| AbstractList | At high concentration (50 micrograms/ml), diallyl trisulfide (DATS) had an inhibitory effect on T cell activation (compared with control group, P < 0.05). But at appropriate concentrations (3.125-12.5 micrograms/ml), DATS augmented the activation of T lymphocytes by Con A (compared with control group, P < 0.01). The augmentation of T cell activation by DATS was related to its inhibitory effect on the production of nitric oxide (NO) by macrophages. In a wide range of concentrations (1-100 micrograms/ml), DATS can inhibit the production of NO by macrophages (P < 0.05, P < 0.01). In addition, DATS can antagonize the inhibition of tumor-derived immunosuppressive factors produced by S180 cells and Ehrlich ascitic cancer cells on the activation of T cells, and reduce the inhibitory rate significantly (P < 0.01). DATS, despite its inhibition of the production of NO by macrophages, can significantly enhance the production of hydrogen peroxide (H2O2) by macrophages. When macrophages were pretreated with DATS for 24 h, the cytotoxicity % of macrophages to three tumor cell lines was significantly higher than that in corresponding control group (P < 0.05, P < 0.01). In the presence of both DATS and LPS, the cytotoxicity of macrophages was further enhanced so that the cytotoxicity % of macrophages to tumor cells was significantly higher than either that in the presence of DATS alone or that in the presence of LPS alone (P < 0.05, P < 0.01). These results indicate that DATS can augment the activation of T cells and enhance the anti-tumor function of macrophage, suggesting that DATS may be potentially useful in tumor therapy. |
| Author | Hao, T L Zhou, B Zhang, G M Zhang, H Jiang, Z Y Feng, Z H |
| Author_xml | – sequence: 1 givenname: Z H surname: Feng fullname: Feng, Z H organization: Department of Medical Molecular Biology, Tongji Medical University, Wuhan – sequence: 2 givenname: G M surname: Zhang fullname: Zhang, G M – sequence: 3 givenname: T L surname: Hao fullname: Hao, T L – sequence: 4 givenname: B surname: Zhou fullname: Zhou, B – sequence: 5 givenname: H surname: Zhang fullname: Zhang, H – sequence: 6 givenname: Z Y surname: Jiang fullname: Jiang, Z Y |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7807598$$D View this record in MEDLINE/PubMed |
| BookMark | eNotT0tLAzEYzKFSa-3Fu5A_sJpkzeuopVWh4KWCFylfXjaSfbCbivvvDdi5DAMzw8wVmrVd6xG6oeSOEiLvn7aEKSWkfpihBWFcVpKKj0u0GsdvUlAzTWo9R3OpiORaLdDnJgRvM-4CdhFSmhLOQxxPKUTncdfifPQYbI4_kGORxbfH1qeEoXW4ATt0_RG-fNX4ks_eYTvlLne_0cY8XaOLAGn0qzMv0ft2s1-_VLu359f1466yjPFcgTO6dtZrLoEGzoRkRlClOBimgQMXlAptBaNBc0WscEyWiNFaGuV5YEt0-9_bn0wZcuiH2MAwHc432R-un1Tv |
| CitedBy_id | crossref_primary_10_1016_S0271_5317_01_00269_X crossref_primary_10_1586_14787210_1_2_319 crossref_primary_10_3390_cancers16020378 crossref_primary_10_3390_ph15081029 crossref_primary_10_1078_0944_7113_00093 crossref_primary_10_6000_1929_5634_2012_01_01_5 crossref_primary_10_1002_tox_22005 crossref_primary_10_1111_j_1740_0929_2011_00918_x crossref_primary_10_1016_j_fsi_2020_05_051 crossref_primary_10_3109_08923970009016413 crossref_primary_10_3390_ani14030498 crossref_primary_10_1007_BF02897671 crossref_primary_10_22159_ajpcr_2022_v15i5_44374 crossref_primary_10_1016_S0166_3542_03_00087_1 crossref_primary_10_1016_S0899_9007_00_00391_9 crossref_primary_10_1007_s13596_021_00574_7 crossref_primary_10_1093_jn_134_4_724 crossref_primary_10_1155_2018_4984659 crossref_primary_10_1158_1535_7163_MCT_08_0216 crossref_primary_10_1016_j_fct_2011_11_027 crossref_primary_10_1016_j_pharmthera_2020_107687 crossref_primary_10_1016_j_pt_2005_08_004 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1007/BF02886794 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 7807598 |
| Genre | Journal Article |
| GroupedDBID | .86 .VR 06C 29L 2J2 2KG 2LR 30V 408 40D 8UJ 95- 95. 95~ 96X AABHQ ABFTV ABJOX ABKCH ABQSL ADURQ ADYFF AEGNC AEXYK AGDGC AHYZX AJRNO ALMA_UNASSIGNED_HOLDINGS AMKLP AZFZN B-. BA0 BBWZM BGNMA CGR CSCUP CUY CVF DPUIP ECM EIF F5P G-Y G-Z GQ7 IXD I~Z KOV M4Y MA- N2Q NF0 NPM NQJWS NU0 O93 O9G O9I O9J P19 P9S PF0 PT5 QOK QOR QOS ROL RPX RSV S16 S37 S3B SAP SCL SDH SHX SMD SOJ SZ9 SZN TUC U2A VC2 ~A9 |
| ID | FETCH-LOGICAL-c225t-adb93dce957a1f52672b61885ab29a5a561169c621f9580c6d27db9b997b8e5f2 |
| ISSN | 0257-716X |
| IngestDate | Thu Jan 02 21:43:45 EST 2025 |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 3 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c225t-adb93dce957a1f52672b61885ab29a5a561169c621f9580c6d27db9b997b8e5f2 |
| PMID | 7807598 |
| ParticipantIDs | pubmed_primary_7807598 |
| PublicationCentury | 1900 |
| PublicationDate | 1994-09-00 |
| PublicationDateYYYYMMDD | 1994-09-01 |
| PublicationDate_xml | – month: 09 year: 1994 text: 1994-09-00 |
| PublicationDecade | 1990 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China |
| PublicationTitle | Journal of Tongji Medical University |
| PublicationTitleAlternate | J Tongji Med Univ |
| PublicationYear | 1994 |
| References | 6778929 - J Immunol Methods. 1980;38(1-2):161-70 6932528 - J Natl Cancer Inst. 1980 Oct;65(4):781-9 6606682 - J Immunol Methods. 1983 Dec 16;65(1-2):55-63 6975316 - J Immunol. 1981 Dec;127(6):2300-7 3511150 - J Immunol Methods. 1986 Jan 22;86(1):39-44 3139757 - J Immunol. 1988 Oct 1;141(7):2407-12 1909732 - J Immunol. 1991 Sep 15;147(6):1816-22 776393 - Cancer Res. 1976 Jul;36(7 PT 1):2360-4 |
| References_xml | – reference: 1909732 - J Immunol. 1991 Sep 15;147(6):1816-22 – reference: 3139757 - J Immunol. 1988 Oct 1;141(7):2407-12 – reference: 6778929 - J Immunol Methods. 1980;38(1-2):161-70 – reference: 3511150 - J Immunol Methods. 1986 Jan 22;86(1):39-44 – reference: 6975316 - J Immunol. 1981 Dec;127(6):2300-7 – reference: 776393 - Cancer Res. 1976 Jul;36(7 PT 1):2360-4 – reference: 6932528 - J Natl Cancer Inst. 1980 Oct;65(4):781-9 – reference: 6606682 - J Immunol Methods. 1983 Dec 16;65(1-2):55-63 |
| SSID | ssj0000329039 |
| Score | 1.2960253 |
| Snippet | At high concentration (50 micrograms/ml), diallyl trisulfide (DATS) had an inhibitory effect on T cell activation (compared with control group, P < 0.05). But... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 142 |
| SubjectTerms | Allyl Compounds - pharmacology Animals Cytotoxicity, Immunologic - drug effects Garlic Humans Lymphocyte Activation - drug effects Macrophages, Peritoneal - physiology Mice Plants, Medicinal Sarcoma 180 - pathology Sulfides - pharmacology T-Lymphocytes - immunology Tumor Cells, Cultured |
| Title | Effect of diallyl trisulfide on the activation of T cell and macrophage-mediated cytotoxicity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/7807598 |
| Volume | 14 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS98wEA_TMfFF1Cm6zZEH36TSpk3SPMrQiahPFb4IIknabBVtBavo_novP2z7VTecL6E0aWlzn1yvd7nPIbQpjVbaRRgVsU2SRlIxE5lYUSJyliuXKHx0zPZPsoMJnYwipja7pFPb-s-reSXvkSqcA7naLNn_kGx_UzgBxyBfaEHC0L5JxoF6GOw9m_5x-WD3jdc3t5emLqsQBXBkGXe9XVhsWU-9ixhcSVu96zfok8ilj1jTUz90bdfe17rupsK9I7O1aJtfF3Uf4Bk2dgxGpVcfp0PeQ--V_jlyvkrnpC22DodR7a2D2-CJ8JTC4skT4RUWLP8I_r8mU9o1G6EoHanKxLNqvVDh8dPGdJJbMsBsPAim__rKCZNbEmVfv_qfnc_ItEPPDJrh3Bb6OA6-HffdTomIXem5_kWm-WzDA82jT-E2z35FnElSLKKFIBS844GxhD5UzTKaOwq7JT6jM48P3Boc8IEHfOC2wYAPPODDjiuwxQcGfOBX8IHH-FhBJ3u7xY_9KJTTiDQo7S6SpRJpqStBuUwMJYwTxZI8pxKWqaQSLOmECc1IYgTNY81KwuESJQRXeUUNWUWzTdtUawgnPM1kBcaz4TojOs41pdxSRzIRq7Ss1tGqn5jza8-Zch5m7MvfOr6i-QFS39BHA0u02gB7r1PfnZgeAVNbVEU |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+diallyl+trisulfide+on+the+activation+of+T+cell+and+macrophage-mediated+cytotoxicity&rft.jtitle=Journal+of+Tongji+Medical+University&rft.au=Feng%2C+Z+H&rft.au=Zhang%2C+G+M&rft.au=Hao%2C+T+L&rft.au=Zhou%2C+B&rft.date=1994-09-01&rft.issn=0257-716X&rft.volume=14&rft.issue=3&rft.spage=142&rft_id=info:doi/10.1007%2FBF02886794&rft_id=info%3Apmid%2F7807598&rft_id=info%3Apmid%2F7807598&rft.externalDocID=7807598 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0257-716X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0257-716X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0257-716X&client=summon |